PRLD 内幕交易 Insider Trades
PRLD 的 SEC Form 4 内幕交易记录 SEC Form 4 insider transaction records for PRLD
总交易 Total
22
买入 Buys
6
买入总额 Total Buys
$35.0M
卖出总额 Total Sells
-
| 信号 Signal | 内幕人 Insider | 职位 Title | 方向 Type | 股数 Shares | 价格 Price | 金额 Amount | 日期 Date | 信号原因 Reasons |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(55) | ORBIMED ADVISORS LLC | - | 买入 Buy | 1,689,189 | $4.44 | $7.5M | 2026-04-21 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(55) | BONITA DAVID P | - | 买入 Buy | 1,689,189 | $4.44 | $7.5M | 2026-04-21 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(55) | BAKER BROS. ADVISORS LP | - | 买入 Buy | 2,137,651 | $4.44 | $9.5M | 2026-04-21 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(50) | BONITA DAVID P | - | 买入 Buy | 1,126,126 | $4.44 | $5.0M | 2026-04-21 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(50) | ORBIMED ADVISORS LLC | - | 买入 Buy | 1,126,126 | $4.44 | $5.0M | 2026-04-21 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(45) | BAKER BROS. ADVISORS LP | - | 买入 Buy | 114,601 | $4.44 | $509K | 2026-04-21 | 董事买入, 大股东(>10%)买入 |
| ★★★★★(0) | BABLER MARTIN | - | 卖出 Sell | 38,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | FRIEDMAN PAUL A | - | 卖出 Sell | 38,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | BONITA DAVID P | - | 卖出 Sell | 38,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | DORTON KATINA | - | 卖出 Sell | 38,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | BAKER BROS. ADVISORS LP | - | 卖出 Sell | 38,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | SANDOR VICTOR | - | 卖出 Sell | 38,000 | - | - | 2026-06-09 | |
| ★★★★★(0) | MORRIS CHARLES Q | Chief Medical Officer | 卖出 Sell | 450,000 | $4.70 | $2.1M | 2026-05-01 | |
| ★★★★★(0) | RA CAPITAL MANAGEMENT, L.P. | - | 卖出 Sell | 1,407,000 | - | - | 2026-04-27 | |
| ★★★★★(0) | RA CAPITAL MANAGEMENT, L.P. | - | 卖出 Sell | 0 | - | - | 2026-04-21 | |
| ★★★★★(0) | ORBIMED ADVISORS LLC | - | 卖出 Sell | 0 | - | - | 2026-04-21 | |
| ★★★★★(0) | BONITA DAVID P | - | 卖出 Sell | 0 | - | - | 2026-04-21 | |
| ★★★★★(0) | BRUSKY SEAN P. | Chief Business Officer | 卖出 Sell | 0 | - | - | 2026-03-05 | |
| ★★★★★(0) | VADDI KRISHNA | CEO | 卖出 Sell | 837,000 | - | - | 2026-02-04 | |
| ★★★★★(0) | SCHERLE PEGGY | Chief Scientific Officer | 卖出 Sell | 230,000 | - | - | 2026-02-04 | |
| ★★★★★(0) | LIM BRYANT DAVID | CLO, CFO, Corp Sec. | 卖出 Sell | 275,000 | - | - | 2026-02-04 | |
| ★★★★★(0) | COMBS ANDREW | Chief Chemistry Officer | 卖出 Sell | 230,000 | - | - | 2026-02-04 |